Table 3 Allele and genotype frequencies of the TAFI polymorphisms in ACI patients and controls
TAFI Polymorphisms | Frequency | |
|---|---|---|
Cases (n = 225) | Controls (n = 184) | |
−2345 2G/1G |  |  |
2G/2G | 66(29.3%) | 42(22.8%) |
2G/1G | 125(55.6%) | 97(52.7%) |
1G/1G | 34(15.1%)* | 45(24.5%) |
2G | 257(57.1%) | 181(49.2%) |
1G | 193(42.9%)* | 187(50.8%) |
−1690 A/G |  |  |
AA | 110(48.9%)* | 72(39.1%) |
AG | 96(42.7%) | 86(46.7%) |
GG | 19(8.4%) | 26(14.2%) |
A | 316(70.2%)* | 230(62.5%) |
G | 134(29.8%) | 138(37.5%) |
−438A/G |  |  |
GG | 122(54.2%) | 108(58.7%) |
GA | 87(38.7%) | 67(36.4%) |
AA | 16(7.1%) | 9(4.9%) |
G | 331(73.6%) | 283(77.0%) |
A | 119(26.4%) | 85(23.0%) |
+1583 A/T | Â | Â |
TT | 129(57.3%) | 99(53.8%) |
TA | 81(36.0%) | 78(42.4%) |
AA | 15(6.7%) | 7(3.8%) |
T | 339(75.3%) | 276(75.0%) |
A | 111(24.7%) | 92(25.0%) |